I don’t believe they intend to use Healey, rather they will use Neals.
From my research it seems Healey is 100% designs for the USA (only) framework. It is not flexible because any drug joining the Healey Platform is just a regimen and it is plug and play. If the requirements for MPL approval in EU and AU are not covered in the Healey framework, too bad. My understanding is that it may not be suitable.
Neals on the other hand can be designed and run to the precise requirements to cover all locations regulatory needs.
so from the presentation yesterday, looks like the company is parking up Healey and going with Neals consortium. They are equally amazing!
one other thing I have been uncovering is that while Healey has some cost profile efficiencies, they are maybe not material and that is without having to pay to cover regulatory gaps for USA patients to be utilised for EU and AU approvals
- Forums
- ASX - By Stock
- PAA
- PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-85
-
- There are more pages in this discussion • 894 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.65M |
Open | High | Low | Value | Volume |
17.0¢ | 18.0¢ | 17.0¢ | $94.51K | 540.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 262452 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 257278 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 262452 | 0.170 |
10 | 190400 | 0.165 |
6 | 141500 | 0.160 |
4 | 512800 | 0.155 |
10 | 378999 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 257278 | 8 |
0.185 | 264496 | 4 |
0.190 | 268528 | 5 |
0.195 | 233327 | 5 |
0.200 | 1144778 | 15 |
Last trade - 12.25pm 15/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online